💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for GlycoMimetics, Inc. (GLYC)
« Back to company indexGLYC Chatter Timeline
Stock Ticker for GLYC
Most Active Tweeters for GLYC
| User | Tweets |
|---|---|
| @BuyerHigh | 9 |
| @gcassidy718 | 7 |
| @BlueBioNow | 6 |
| @rmacmillan310 | 4 |
| @MaisaCorp | 2 |
Recent Tweets for GLYC
 |
@newsfilterio GlycoMimetics to Report Third Quarter Financial Results on November 6, 2020 $GLYC https://t.co/BZUujW0n1g October 30th 2020, 1:10pm |
 |
@stock_titan $GLYC GlycoMimetics to Report Third Quarter Financial Results on November 6, 2020 https://t.co/YSLxPusjEL October 30th 2020, 9:10am |
 |
@FlashAlert_me $GLYC [15s. delayed]: Issued Press Release on October 30, 09:00:00: GlycoMimetics to Report Third Quarter Financial… https://t.co/kaXJQ1WIeN October 30th 2020, 9:10am |
 |
@gcassidy718 $GLYC here we go!! -2.35 % change recently https://t.co/OpTFVD2XBu October 30th 2020, 7:10am |
|
@gcassidy718 $GLYC definitely going to finish under $2.68 -8.59 % change recently https://t.co/OpTFVD2XBu October 29th 2020, 11:10pm |
 |
@rmacmillan310 $GLYC I’ll probably buy on the dip. Still need to do more research. -8.59 % https://t.co/4HAc7KkPtG October 29th 2020, 6:10pm |
 |
@BuyerHigh RT @ChartMill: The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/coby5oRXJT October 29th 2020, 6:10pm |
 |
@ChartMill The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/coby5oRXJT October 28th 2020, 10:10pm |
 |
@DayTradeMachine $GLYC Potential @ Price : 2.99 October 28th 2020, 3:10pm |
|
@BuyerHigh RT @MaisaCorp: $GLYC said it is in discussions with the US Food and Drug Administration about how to proceed with development of the drug… October 27th 2020, 10:10pm |
|
@BuyerHigh RT @MaisaCorp: $GLYC presented additional Phase III clinical data at a scientific meeting for its drug candidate rivipansel in the treatmen… October 27th 2020, 10:10pm |
|
@rmacmillan310 $GLYC wow what a great surprise 2.79 % https://t.co/4HAc7KkPtG October 27th 2020, 7:10pm |
 |
@equity_newswire $GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/C8vDrkqNSu October 27th 2020, 3:10pm |
 |
@WhyteStocks News; $GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The $GLYC… https://t.co/rHTBUjhNvK October 26th 2020, 11:10pm |
 |
@MaisaCorp $GLYC said it is in discussions with the US Food and Drug Administration about how to proceed with development of… https://t.co/sTh8moD4rM October 26th 2020, 7:10pm |
|
@MaisaCorp $GLYC presented additional Phase III clinical data at a scientific meeting for its drug candidate rivipansel in the… https://t.co/TXN8omWmDr October 26th 2020, 7:10pm |
 |
@CloverResearch $GLYC always love a post-hoc, let’s search for SOMETHING good, analysis. October 26th 2020, 4:10pm |
|
@BuyerHigh RT @MarketCurrents: $GLYC - GlycoMimetics announces new rivipansel data in sickle cell disease https://t.co/cdMBMnT7hZ October 26th 2020, 3:10pm |
|
@BuyerHigh RT @newsfilterio: GlycoMimetics announces new rivipansel data in sickle cell disease $GLYC https://t.co/2qSVaZJr1x October 26th 2020, 3:10pm |
|
@newsfilterio GlycoMimetics announces new rivipansel data in sickle cell disease $GLYC https://t.co/2qSVaZJr1x October 26th 2020, 12:10pm |
 |
@HealthcareBeat GlycoMimetics announces new rivipansel data in sickle cell disease $GLYC https://t.co/sT1FaHeycC October 26th 2020, 12:10pm |
 |
@MarketCurrents $GLYC - GlycoMimetics announces new rivipansel data in sickle cell disease https://t.co/cdMBMnT7hZ October 26th 2020, 12:10pm |
 |
@Briefingcom $GLYC: GlycoMimetics presents new post hoc analyses of the Phase 3 RESET study evaluating the efficacy of rivipanse… https://t.co/90oc7Wdrzc October 26th 2020, 11:10am |
 |
@MarcJacksonLA $GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/fzUpVYJUfh October 26th 2020, 10:10am |
|
@stock_titan $GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/nJMeGRoL1J October 26th 2020, 9:10am |
 |
@otcdynamics $GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/aK25jpZ5uM October 26th 2020, 9:10am |
 |
@sbwcws GlycoMimetics announces new post hoc analyses of rivipansel study $GLYC October 26th 2020, 9:10am |
|
@gcassidy718 $GLYC major moves #GLYC -4.49 % change recently https://t.co/OpTFVD2XBu October 22nd 2020, 5:10pm |
|
@rmacmillan310 $GLYC Stock is under performing. . . -4.19 % change recently https://t.co/4HAc7KkPtG October 22nd 2020, 10:10am |
 |
@thestockkira $GLYC buying here to low 3s October 22nd 2020, 10:10am |
 |
@BlueBioNow $GLYC major stock movement -4.49 % change recently https://t.co/XgwQoI5WeD October 22nd 2020, 6:10am |
 |
@WeekHerald Analysts Expect GlycoMimetics, Inc. $GLYC to Post -$0.33 EPS https://t.co/yNIzvef967 October 21st 2020, 3:10pm |
 |
@OlympiaReport Analysts Expect GlycoMimetics, Inc. $GLYC to Post -$0.33 EPS https://t.co/q9mNAD6sJ0 October 21st 2020, 3:10pm |
 |
@AmericanBanking Analysts Expect GlycoMimetics, Inc. $GLYC to Post -$0.33 EPS https://t.co/zHoG9GIHo9 #stocks October 21st 2020, 3:10pm |
|
@thestockkira $GLYC next support leg is 3.06, I'll buy again for a swing there, made 20%-25% twice on this one October 21st 2020, 1:10pm |
|
@BuyerHigh RT @ChartMill: The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/r0pKZQbvlt October 21st 2020, 8:10am |
|
@ChartMill The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/r0pKZQbvlt October 21st 2020, 7:10am |
|
@gcassidy718 $GLYC substantial price changes on this stock -2.09 % https://t.co/OpTFVD2XBu October 21st 2020, 2:10am |
|
@BlueBioNow $GLYC a bit volatility -2.09 % change recently https://t.co/XgwQoI5WeD October 21st 2020, 1:10am |
|
@BlueBioNow $GLYC Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 2.13 % change recently https://t.co/XgwQoI5WeD October 19th 2020, 7:10pm |
 |
@SwingTradeBot 20 DMA Support today: $GLYC ... https://t.co/deOpbNqdR6 October 19th 2020, 3:10pm |
|
@BlueBioNow $GLYC buyer at $3.69 2.13 % change recently https://t.co/XgwQoI5WeD October 19th 2020, 11:10am |
|
@rmacmillan310 $GLYC headed twds $3.69 . EOQ 2.13 % change recently https://t.co/4HAc7KkPtG October 19th 2020, 1:10am |
|
@BlueBioNow $GLYC substantial stock price changes 2.13 % change recently https://t.co/XgwQoI5WeD October 18th 2020, 9:10pm |
|
@BlueBioNow $GLYC blockbuster 2.13 % change recently https://t.co/XgwQoI5WeD October 18th 2020, 7:10am |
|
@gcassidy718 $GLYC buyer at $3.69 2.13 % change recently https://t.co/OpTFVD2XBu October 18th 2020, 1:10am |
|
@BuyerHigh RT @SeekingAlpha: $GLYC - GlycoMimetics' Possible Rivipansel Revival. https://t.co/gaVJmDqndh #stockmarket #investing #finance October 17th 2020, 2:10pm |
|
@BuyerHigh RT @HealthcareBeat: GlycoMimetics' Possible Rivipansel Revival $GLYC https://t.co/PvHG68deph October 17th 2020, 2:10pm |
|
@BuyerHigh RT @Moor_Gamma: Nice timing @CowenResearch ? $GLYC https://t.co/Im1Q4s6Y9b October 17th 2020, 2:10pm |
|
@gcassidy718 $GLYC The Broad market is turning Green .. Big Green Reversal coming? 2.13 % change recently https://t.co/OpTFVD2XBu October 17th 2020, 11:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
